Abstract
BACKGROUND: Current first-line treatment for social anxiety disorder (SAD), one of the most prevalent anxiety disorders, is limited in its efficacy. Hence, novel treatment approaches are urgently needed. The current review suggests a combination of meditation-based interventions and the administration of a psychedelic as a future alternative treatment approach. While both separate treatments show promise in the treatment of (other) clinical conditions, their combination has not yet been investigated in the treatment of psychopathologies.
AIM: With a systematic literature review, we aim to identify the potential mechanisms by which combined psilocybin and mindfulness treatment could adjust anomalous neural activity underlying SAD and exert therapeutic effects.
RESULTS: Thirty experimental studies investigating the neural effects of meditation or psilocybin treatment in healthy and patient samples were included. Findings suggest that psilocybin-assisted meditation interventions might change cognitive processes like biased attention to threat linked to SAD by modulating connectivity of the salience network, balancing the activity and connectivity of cortical-midline structures, and increasing frontoparietal control over amygdala reactivity.
CONCLUSIONS: Future studies should investigate whether psilocybin-assisted mindfulness-based intervention can provide therapeutic benefits to SAD patients who are do not remit following conventional therapy.
Original language | English |
---|---|
Article number | 104724 |
Number of pages | 13 |
Journal | Neuroscience and Biobehavioral Reviews |
Volume | 139 |
Early online date | 6 Jun 2022 |
DOIs | |
Publication status | Published - Aug 2022 |
Keywords
- CEREBRAL-BLOOD-FLOW
- COGNITIVE-BEHAVIORAL THERAPY
- EMOTION REGULATION
- EPIDEMIOLOGY
- FMRI
- LSD
- MODE NETWORK ACTIVITY
- Mindfulness meditation
- PHOBIA
- Psilocybin
- STATE FUNCTIONAL CONNECTIVITY
- STRESS REDUCTION PROGRAM
- Social anxiety disorder